Biomarin Pharmaceutical (BMRN) Equity Income (2009 - 2021)
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Equity Income (2009 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 4.08 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Biomarin Pharmaceutical | 12.84 Bn | 11.97 Bn | 786.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 177,000.00 |
| Jun 30, 2021 | -175,000.00 |
| Mar 31, 2021 | -1.35 Mn |
| Dec 31, 2020 | 1.07 Mn |
| Sep 30, 2020 | -921,000.00 |
| Jun 30, 2020 | -79,000.00 |
| Mar 31, 2020 | -77,000.00 |
| Dec 31, 2019 | 193,000.00 |
| Sep 30, 2019 | -551,000.00 |
| Jun 30, 2019 | -44,000.00 |
| Mar 31, 2019 | -185,000.00 |
| Dec 31, 2018 | -46,000.00 |
| Sep 30, 2018 | -468,000.00 |
| Jun 30, 2018 | -107,000.00 |
| Mar 31, 2018 | 68,000.00 |
| Dec 31, 2017 | -295,000.00 |
| Sep 30, 2017 | -253,000.00 |
| Jun 30, 2017 | -220,000.00 |
| Mar 31, 2017 | -523,000.00 |
| Dec 31, 2016 | -164,000.00 |